232 related articles for article (PubMed ID: 15352293)
1. Fighting foot and toenail fungus.
Health News; 1999 Aug; 5(10):7. PubMed ID: 15352293
[No Abstract] [Full Text] [Related]
2. [Terbinafine (Lamisil)].
Breton MC
Union Med Can; 1995 Nov; 124(3):20-5. PubMed ID: 8560634
[No Abstract] [Full Text] [Related]
3. Onychomycosis and terbinafine.
Lancet; 1990 Mar; 335(8690):636. PubMed ID: 1969022
[No Abstract] [Full Text] [Related]
4. Terbinafine for the treatment of pedal onychomycosis. A foot closer to the promised land of cured nails?
Shear NH; Gupta AK
Arch Dermatol; 1995 Aug; 131(8):937-42. PubMed ID: 7632066
[TBL] [Abstract][Full Text] [Related]
5. Terbinafine: an oral and topical antifungal agent.
Shear NH; Villars VV; Marsolais C
Clin Dermatol; 1991; 9(4):487-95. PubMed ID: 1840406
[No Abstract] [Full Text] [Related]
6. Athlete's foot and fungally infected toe nails.
Crawford F
Clin Evid; 2002 Jun; (7):1458-66. PubMed ID: 12230762
[No Abstract] [Full Text] [Related]
7. Tinea and Onychomycosis.
Rosen T
Semin Cutan Med Surg; 2016 Jun; 35(6 Suppl):S110-3. PubMed ID: 27537822
[TBL] [Abstract][Full Text] [Related]
8. Treatment of toenail tinea infection. True cure seems unlikely.
Buck DS
BMJ; 1996 Feb; 312(7026):312-3. PubMed ID: 8611806
[No Abstract] [Full Text] [Related]
9. Clinical inquiries. What is the most effective treatment for tinea pedis (athlete's foot)?
Markova T
J Fam Pract; 2002 Jan; 51(1):21. PubMed ID: 11927056
[No Abstract] [Full Text] [Related]
10. In vitro antifungal susceptibility of dermatophyte strains causing tinea pedis and onychomycosis in patients with non-insulin-dependent diabetes mellitus: a case-control study.
Ozcan D; Seçkin D; Demirbilek M
J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1442-6. PubMed ID: 20384680
[TBL] [Abstract][Full Text] [Related]
11. [Lamisil in the therapy of foot mycoses].
Vladimirov VV
Ter Arkh; 1993; 65(10):71-3. PubMed ID: 8296240
[TBL] [Abstract][Full Text] [Related]
12. [Diabetic foot syndrome, 6. Diagnosis and treatment of mycoses].
Agathos M
MMW Fortschr Med; 2000 Nov; 142(44):38-9. PubMed ID: 11107803
[No Abstract] [Full Text] [Related]
13. Short-duration therapy for superficial tinea infections.
Elewski BE
Am Fam Physician; 1994 May; 49(6):1349-50. PubMed ID: 8172031
[No Abstract] [Full Text] [Related]
14. Reversible agranulocytosis associated with oral terbinafine in a pediatric patient.
Aguilar C; Mueller KK
J Am Acad Dermatol; 2001 Oct; 45(4):632-4. PubMed ID: 11568763
[TBL] [Abstract][Full Text] [Related]
15. [Study on patient satisfaction with the treatment of mycosis on the extremities with terbinafine (SETTA)].
Sánchez-Schmidt JM; Giménez-Jovani S; Peyrí-Rey J
Actas Dermosifiliogr; 2005 Jun; 96(5):285-90. PubMed ID: 16476388
[TBL] [Abstract][Full Text] [Related]
16. Athlete's foot.
Crawford F
Clin Evid; 2004 Dec; (12):2266-70. PubMed ID: 15865786
[No Abstract] [Full Text] [Related]
17. Athlete's foot.
Crawford F
Clin Evid; 2004 Jun; (11):2128-32. PubMed ID: 15652103
[No Abstract] [Full Text] [Related]
18. A reliable topical antifungal for podiatry.
Frohlich HT; Irons WG; Ceder ET
J Am Podiatry Assoc; 1967 Apr; 57(4):177-9. PubMed ID: 4227177
[No Abstract] [Full Text] [Related]
19. Treatment of dermatomycoses with dibenzthione.
Ziprkowski L
Dermatol Int; 1965; 4(3):169-71. PubMed ID: 4226107
[No Abstract] [Full Text] [Related]
20. Topical butenafine for tinea pedis.
Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
